期刊文献+

NLRP3炎性体在2型糖尿病合并糖尿病足患者中的作用 被引量:4

The role of NLRP3 inflammasome in patients with type 2 diabetes with diabetic foot
原文传递
导出
摘要 目的探讨NLRP3炎性体在2型糖尿病合并糖尿病足患者中的作用。方法自2016年6月—2017年6月,前瞻性收集丽水市第二人民医院收治的2型糖尿病合并糖尿病足患者100例作为观察组,同期收集2型糖尿病患者50例(无糖尿病足)作为对照组。观察2组患者NLRP3炎性体表达情况。另外收集观察组患者主要临床特征,分析NLRP3炎性体与2型糖尿病足患者临床特征的相关性。结果与对照组比较,观察组患者NLRP3炎性小体mRNA相对表达量显著增高(4.12±0.88 vs.2.73±0.92,P<0.001);NLRP3炎性小体蛋白质相对表达量显著增高(12.48±2.81 vs.9.89±2.65,P<0.001)。糖尿病严重程度分级为0~1、2~3和4~5级的患者NLRP3炎性小体mRNA相对表达量分别为3.27±0.78、3.87±0.83、4.83±0.92,差异有统计意义(P=0.002);NLRP3炎性小体蛋白质相对表达量分别为9.65±2.12、11.32±2.54、15.49±2.98,差异有统计学意义(P<0.001)。Pearson线性相关性分析显示NLRP3炎性小体mRNA相对表达量、NLRP3炎性小体蛋白质相对表达量均与糖尿病足严重程度评分、糖化血红蛋白浓度成正相关(P<0.05)。结论 2型糖尿病合并糖尿病足患者NLRP3炎性体激活,与糖尿病足的发生发展过程有关。 Objective To investigate the role of NLRP3 inflammasome in type 2 diabetes mellitus with diabetic foot. Methods From June, 2016 to June, 2017, 100 patients with type 2 diabetes mellitus and diabetic foot treated in our hospital were selected as an observation group, and 50 patients with type 2 diabetes mellitus (without diabetic foot) were selected as a control group. The expression of NLRP3 between the two groups were observed. In addition, the main clini- cal features of the patients in the observation group were collected, and the correlation between the NLRP3 inflammasome and the clinical features of diabetic foot were analyzed. Results When compared with the control group, the relative ex- pression of mRNA of the NLRP3 inflammasome increased significantly in the observation group(d. 12 ± 0.88 vs. 2.73 ± 0.92, P 〈0.001 ), and the relative expression level of NLRP3 inflammasome protein increased significantly( 12.48 ± 2.81 vs. 9.89±2.65, P〈0.001). The NLRP3 inflammasome mRNA expression in patients of 0- 1, 2 -3 and d -5 Diabetes severity grading were 3.27 ± 0.78, 3.87 ± 0.83 arid 4.83 ± 0.92, the difference was statistically significant (P = 0.002). NLRP3 inflammasome protein expression levels were 9.65 ± 2.12, 11.32 ± 2.54 and 15.49 ± 2.98, the difference was statistically significant ( P 〈 0.001 ). Pearson linear correlation analysis showed that the relative expression level of NLRP3 mRNA and the relative expression of NLRP3 inflammasome protein were all directly proportional to the di- abetic foot severity score and glycosylated hemoglobin (P 〈 0.05). Conclusion The activation of NLRP3 inflammasome in patients with type 2 diabetes mellitus combined with diabetic foot is related to the development of diabetic foot.
作者 王仙凤 李丽红 洪宝建 WANG Xian-feng;LI Li-hong;HONG Bao-jian(Department of Clinical Laboratory, the Second People's Hospital of Lishui, Lishui, Zhejiang 323000, Chin)
出处 《中华全科医学》 2018年第5期785-787,共3页 Chinese Journal of General Practice
基金 2016年浙江省医药卫生一般研究项目(2016ZYC-A40)
关键词 NLRP3炎性体 2型糖尿病 糖尿病足 NLRP3 inflammasome Type 2 diabetes Diabetic foot
作者简介 通信作者:王仙凤,E-mail:1637737316@qq.com
  • 相关文献

参考文献1

二级参考文献32

  • 1Meylan E, Tschopp J, Karin M. Intracellular pattern recognitionreceptors in the host response[J]. Nature, 2006, 442(7098): 39-44.
  • 2Ting JP, Willingham SB, Bergstralh DT. NLRs at the intersection ofcell death and immunity[J]. Nat Rev Immunol, 2008, 8(5): 372-379.
  • 3Kanneganti TD, Lamkanfi M, Kim YG, et al. Pannexin-1-m ediatedrecognition of bacterial m olecules activates the cryopyrininflammasome independent of Toll-like receptor signaling[J].Immunity, 2007, 26(4): 433-443.
  • 4Marina-García N, Franchi L, Kim YG, et al. Pannexin-1-mediatedintracellular delivery of muramyl dipeptide induces caspase-1activation via cryopyrin /NLRP3 independently of Nod2[J]. JImmunol, 2008, 180(6): 4050-4057.
  • 5Halle A, Hornung V, Petzold GC, et al. The NALP3 inflammasome isinvolved in the innate immune response to am yloid-beta[J]. NatImmunol, 2008, 9(8): 857-865.
  • 6Hornung V, Bauernfeind F, Halle A, et al. Silica crystals andaluminum salts activate the NALP3 inflammasome throughphagosomal destabilization[J]. Nat Immunol, 2008, 9(8): 847-856.
  • 7Cassel SL, Eisenbarth SC, Iyer SS. et al. The Nalp3 inflammasome isessential for the development of silicosis[J]. Proc Natl Acad Sci U SA, 2008, 105(26): 9035-9040.
  • 8Dostert C, Pétrilli V, Van Bruggen R, et al. Innate immune activationthrough Nalp3 inflammasome sensing of asbestos and silica[J].Science, 2008, 320(5876): 674-677.
  • 9Martinon F, Pétrilli V, Mayor A, et al. Gout-associated uric acidcrystals activate the NALP3 inflammasome[J]. Nature, 2006,440(7081): 237-241.
  • 10Larsen CM, Faulenbach M, Vaag A, et al. Sustained effects ofinterleukin-1 receptor antagonist treatment in type 2 diabetes[J].Diabetes Care, 2009, 32(9): 1663-1668.

共引文献9

同被引文献53

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部